Navigation Links
Shoulder Cryo/Cuff™

ProductsShoulder Cryo/Cuff™
Company Aircast
Item Shoulder Cryo/Cuff™
Features 
  • Anatomic cuff design for complete coverage of affected area
  • Measured compression for patient comfort
  • Controlled cold eliminates the risk of tissue damage
  • Detachable cooler allows for uninterrupted treatment
  • Expanded coverage with extra long strap
  • Indications: trauma, post-op, and rehabilitation
    • Description Combining the therapeutic benefits of controlled compression and cold, the Shoulder Cryo/Cuff minimizes hemarthrosis, swelling, and pain. The anatomically designed cuff provides complete shoulder coverage for optimum treatment. The Shoulder Cryo/Cuff can be ordered with an extra long strap (12AXL) to adapt to larger chest circumferences. All Cryo/Cuffs can be ordered as a single cuff, or with a cooler (including a tube assembly and insulation disk). The Cooler is available separately and can be used with any model in the Cryo/Cuff line.
    Info Aircast
    Customer Service: (800) 526-8785
    Web site: http://www.aircast.com/

    Related medicine products :

    1. Foundation Total Shoulder System
    2. Bio-Modular Shoulder System
    3. Bi-Angular / Bi-Polar Shoulder System
    4. Absolute Bi-Polar Shoulder System
    5. Integrated Shoulder System
    6. The Solar Shoulder System
    7. Olympia Total Shoulder System
    8. Bigliani/Flatow The Complete Shoulder Solution
    9. Cofield 2 Total Shoulder System
    10. Neer II* Total Shoulder System
    11. Bio-Modular Total Shoulder System
    ...the rapid, detection of platelet dysfunction. It i... that uniquely simulates the in vivo function of p...s platelet function under high shear conditions si...lood vessel. Testing is performed using a small wh...
    ...rming erythrocyte sedimentation rate (ESR) tests u...es-matic System DIESSE brings to the clinical diag... which addresses and resolves every technical limi...e.,By means of a fully automated analyzer and a es...
    ...n rate analysers, which are especially user-friend...stablished advantages of the existing analysers wi...rantee time-saving standardised analysis of the er...s an essential aspect of daily recurrent routine a...
    Blood sedimentation rate analysis
    Medicine Products:
    (Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
    (Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
    (Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
    (Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
    Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
    ...ve said that people should not unnecessarily panic...cancer. The study, which appears in the Journal of... it was most probably, children and the very elder...The researchers reviewed over 300 studies on the e...
    ...arned a doctor of Indian origin who refused to tre... he was an asylum seeker in Britain. Mahesh Chand...he man treatment because "he was not British and d...C committee has been told. Chandra, who studied ...
    ...manufactured TGN-1412, has now admitted that the d...onkeys. Four out of the six who were admitted to t...following the drug administration are recovering, ...ntroversial clinical trial had been conducted at N...
    ...ut whether sporadic outbreaks of bird flu could in...Although the impact of the H5N1 bird flu infection..., bird flu pandemic could claim a million lives, w...f the lethal viruses to infect birds. However, it ...
    Other Medicine News:Health News:Drug Company Admits Knowledge Of Side Effects In Monkeys 2
    (Date:10/9/2008)...n Campaign to Spread Awareness and Bring Hope to M...PRNewswire-USNewswire/ -- 133 million children,acr...ses such as natural,disaster, civil war, and disea...ving World Orphan Week by calling attention to the...dia News Release, go to:, http://www.prnewswire....
    (Date:10/9/2008)...ical Results Expected in November 2008, BOTHELL, ...ma, Inc.,(Amex: DDD ) announced today the complet... of its three pivotal trials to evaluate the safet...ded-release (ER) ibuprofen for,the over-the-counte...line,results from this pivotal trial in November 2...
    (Date:10/8/2008)...a., Oct. 8 /PRNewswire-USNewswire/ -- The facts ar... from HIV/AIDS in,sub-Saharan Africa. More than 35...frica have already died of AIDS. The Foundation fo...ure the dying and their families,find compassion a...,s,innovative partnering initiative links African ...
    (Date:10/8/2008)... Institute Pioneers Research That May Offer New Ho...Newswire/ -- Nationally, over 3,000 people are,wai...ife. Sadly, only half,of those will receive a tran...Institute (AHI) is paving the way for how to treat...w the Multimedia News Release, go to:, http://www....
    Breaking Medicine Technology:Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 1Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 4NIAID funds 2451M contract to create comprehensive model of immune responses 4419 1NIAID funds 2451M contract to create comprehensive model of immune responses 4419 2Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 4416 1Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 4416 2Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 4416 3Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 4416 4GSI Group Reports Third Quarter Results 4413 1GSI Group Reports Third Quarter Results 4413 2GSI Group Reports Third Quarter Results 4413 3GSI Group Reports Third Quarter Results 4413 4GSI Group Reports Third Quarter Results 4413 5GSI Group Reports Third Quarter Results 4413 6GSI Group Reports Third Quarter Results 4413 7GSI Group Reports Third Quarter Results 4413 8
    ...-FirstCall/ --,Pharmacyclics, Inc. announced today...e deacetylase (HDAC) inhibitor and,Bruton,s tyrosi...ill take place at the American Association for Can... April 14-18, 2007, at the Los,Angeles Convention ...ns are as follows:, Sunday, April 15, 2007, ...
    ...ence in Barcelona,Spain, VANCOUVER and SAN DIEGO,...IX Inc. , a clinical-stage developer,of drugs for ...ults,confirming the previously announced clinical ...clinical benefit, safety and,tolerability in a Pha...itor, celgosivir (MX-3253), in combination with pe...
    Other Medicine Technology:Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8